Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Breakaway Research Group is an independent clinical research site and contract research organization (CRO) based in Spokane, Washington. Founded by board-certified dermatologist Dr. Wm. Philip Werschler, the company specializes in conducting Phase I-IV clinical trials with a strong focus on dermatology, aesthetic medicine, vaccines, and internal medicine. The facility features an overnight Phase I study suite, dedicated photography rooms, and advanced laboratory processing capabilities. Breakaway Research Group provides clinical trial execution, site management, and boutique consulting services to pharmaceutical, biotech, and medical device sponsors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BreakAway Research.